CLINICAL EFFICACY AND SAFETY OF ADEMETIONINE IN PATIENTS WITH DIABETES-ASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
Osteoarthritis (OA) is one of most common rheumatic diseases, and currently there is no effective pharmacological treatment of OA. It has been suggested that lack of effective treatment is, in part, due to the disease heterogeneity which may lead to development of several OA subtypes (phenotypes). D...
Guardado en:
Autores principales: | I. V. Shirinsky, O. V. Sazonova, N. Yu. Kalinovskaya, V. S. Shirinsky |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8170aefa1b65444588771a2cbd96c8ae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
COMORBIDITY, DNA METHYLATION AND AUTOIMMUNITY IN DIABETES-ASSOCIATED OSTEOARTHRITIS: AN EXPLORATORY STUDY
por: I. V. Shirinsky, et al.
Publicado: (2015) -
CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF DIABETES-ASSOCIATED OSTEOARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2015) -
CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
por: V. S. Shirinsky, et al.
Publicado: (2017) -
DIABETES-ASSOCIATED OSTEOARTHRITIS: A SYNTROPY?
por: E. V. Kazygasheva, et al.
Publicado: (2016) -
Clinical and immunological features of metabolic phenotype of osteoarthritis
por: V. S. Shirinsky, et al.
Publicado: (2020)